Package 71921-223-06

Brand: lacosamide

Generic: lacosamide
NDC Package

Package Facts

Identity

Package NDC 71921-223-06
Digits Only 7192122306
Product NDC 71921-223
Description

60 TABLET in 1 BOTTLE (71921-223-06)

Marketing

Marketing Status
Marketed Since 2023-09-21
Brand lacosamide
Generic lacosamide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "85fd1828-d3d9-4b4b-965b-7ed7ef5f5e97", "openfda": {"nui": ["N0000008486"], "upc": ["0371921221066", "0371921222063", "0371921223060"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["3680c0ff-7f5c-4572-b1eb-4fea96b7fbe2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71921-223-06)", "package_ndc": "71921-223-06", "marketing_start_date": "20230921"}], "brand_name": "Lacosamide", "product_id": "71921-223_85fd1828-d3d9-4b4b-965b-7ed7ef5f5e97", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71921-223", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "200 mg/1"}], "application_number": "ANDA208308", "marketing_category": "ANDA", "marketing_start_date": "20230921", "listing_expiration_date": "20261231"}